nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—abdominal aortic aneurysm	0.939	1	CbGaD
Phenylbutazone—PTGIS—artery—abdominal aortic aneurysm	0.0138	0.274	CbGeAlD
Phenylbutazone—PTGIS—connective tissue—abdominal aortic aneurysm	0.0055	0.109	CbGeAlD
Phenylbutazone—PTGS2—leg—abdominal aortic aneurysm	0.0045	0.0896	CbGeAlD
Phenylbutazone—PTGS2—hindlimb—abdominal aortic aneurysm	0.00402	0.08	CbGeAlD
Phenylbutazone—SLC22A11—kidney—abdominal aortic aneurysm	0.00262	0.0521	CbGeAlD
Phenylbutazone—PTGS1—artery—abdominal aortic aneurysm	0.00258	0.0513	CbGeAlD
Phenylbutazone—PTGS2—artery—abdominal aortic aneurysm	0.00247	0.0491	CbGeAlD
Phenylbutazone—CYP2C9—blood plasma—abdominal aortic aneurysm	0.00212	0.0422	CbGeAlD
Phenylbutazone—PTGIS—Nicotinamide salvaging—PTGS2—abdominal aortic aneurysm	0.0021	0.193	CbGpPWpGaD
Phenylbutazone—PTGS1—blood plasma—abdominal aortic aneurysm	0.00194	0.0385	CbGeAlD
Phenylbutazone—PTGS2—blood plasma—abdominal aortic aneurysm	0.00185	0.0368	CbGeAlD
Phenylbutazone—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00162	0.0322	CbGeAlD
Phenylbutazone—SLC22A8—kidney—abdominal aortic aneurysm	0.00148	0.0294	CbGeAlD
Phenylbutazone—PTGIS—Nicotinate metabolism—PTGS2—abdominal aortic aneurysm	0.00112	0.103	CbGpPWpGaD
Phenylbutazone—PTGS1—connective tissue—abdominal aortic aneurysm	0.00103	0.0205	CbGeAlD
Phenylbutazone—PTGS2—connective tissue—abdominal aortic aneurysm	0.000985	0.0196	CbGeAlD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—abdominal aortic aneurysm	0.00092	0.0847	CbGpPWpGaD
Phenylbutazone—PTGS1—kidney—abdominal aortic aneurysm	0.000877	0.0175	CbGeAlD
Phenylbutazone—PTGS2—kidney—abdominal aortic aneurysm	0.000838	0.0167	CbGeAlD
Phenylbutazone—CYP3A4—kidney—abdominal aortic aneurysm	0.000733	0.0146	CbGeAlD
Phenylbutazone—PTGS1—spinal cord—abdominal aortic aneurysm	0.000683	0.0136	CbGeAlD
Phenylbutazone—PTGS2—spinal cord—abdominal aortic aneurysm	0.000653	0.013	CbGeAlD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—abdominal aortic aneurysm	0.000598	0.0551	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—abdominal aortic aneurysm	0.0005	0.0461	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000332	0.0306	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—abdominal aortic aneurysm	0.000283	0.026	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—AGT—abdominal aortic aneurysm	0.000231	0.0212	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—abdominal aortic aneurysm	0.000222	0.0204	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—abdominal aortic aneurysm	0.000213	0.0196	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—abdominal aortic aneurysm	0.000184	0.0169	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.000183	0.0169	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—SERPINE1—abdominal aortic aneurysm	0.000177	0.0163	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—abdominal aortic aneurysm	0.000175	0.0161	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000171	0.0158	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—abdominal aortic aneurysm	0.000154	0.0142	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—abdominal aortic aneurysm	0.000147	0.0135	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.000145	0.0134	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000134	0.0123	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000131	0.012	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000116	0.0107	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000109	0.01	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000102	0.00941	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—LRP1—abdominal aortic aneurysm	9.4e-05	0.00865	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	9.19e-05	0.00846	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	8.7e-05	0.00801	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AAAS—abdominal aortic aneurysm	8.16e-05	0.00751	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	7.98e-05	0.00734	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	7.53e-05	0.00693	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	7.45e-05	0.00685	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—LDLR—abdominal aortic aneurysm	7.12e-05	0.00656	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	7.08e-05	0.00652	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	6.93e-05	0.00638	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AAAS—abdominal aortic aneurysm	6.83e-05	0.00629	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NCF1—abdominal aortic aneurysm	6.66e-05	0.00613	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	6.64e-05	0.00611	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	6.5e-05	0.00598	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	6.33e-05	0.00583	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—LDLR—abdominal aortic aneurysm	5.96e-05	0.00549	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	5.91e-05	0.00544	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN2A—abdominal aortic aneurysm	5.73e-05	0.00527	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	5.64e-05	0.00519	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	5.55e-05	0.00511	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	5.54e-05	0.0051	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	5.37e-05	0.00495	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	5.01e-05	0.00461	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	4.75e-05	0.00437	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	4.48e-05	0.00412	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	4.12e-05	0.00379	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APOE—abdominal aortic aneurysm	3.69e-05	0.00339	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	3.58e-05	0.0033	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOS2—abdominal aortic aneurysm	3.44e-05	0.00316	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	3.27e-05	0.00301	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AGT—abdominal aortic aneurysm	3.15e-05	0.0029	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—APOE—abdominal aortic aneurysm	3.09e-05	0.00284	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SERPINE1—abdominal aortic aneurysm	2.89e-05	0.00266	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—abdominal aortic aneurysm	2.53e-05	0.00233	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	2.41e-05	0.00222	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LRP1—abdominal aortic aneurysm	2.29e-05	0.00211	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	2.18e-05	0.002	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	2.16e-05	0.00199	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	2.13e-05	0.00196	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—abdominal aortic aneurysm	2.12e-05	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AAAS—abdominal aortic aneurysm	2.1e-05	0.00193	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AAAS—abdominal aortic aneurysm	1.99e-05	0.00183	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LDLR—abdominal aortic aneurysm	1.83e-05	0.00169	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LDLR—abdominal aortic aneurysm	1.74e-05	0.0016	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	1.73e-05	0.00159	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	1.69e-05	0.00156	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AAAS—abdominal aortic aneurysm	1.67e-05	0.00153	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NCF1—abdominal aortic aneurysm	1.63e-05	0.0015	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.46e-05	0.00134	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LDLR—abdominal aortic aneurysm	1.46e-05	0.00134	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	1.14e-05	0.00105	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	1.12e-05	0.00103	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	1.1e-05	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AGT—abdominal aortic aneurysm	9.69e-06	0.000892	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	9.64e-06	0.000887	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOE—abdominal aortic aneurysm	9.49e-06	0.000874	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOE—abdominal aortic aneurysm	9e-06	0.000828	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—abdominal aortic aneurysm	8.38e-06	0.000772	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AGT—abdominal aortic aneurysm	7.69e-06	0.000708	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	7.68e-06	0.000707	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOE—abdominal aortic aneurysm	7.54e-06	0.000694	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	7.28e-06	0.00067	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SERPINE1—abdominal aortic aneurysm	7.06e-06	0.00065	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—abdominal aortic aneurysm	6.5e-06	0.000599	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	6.36e-06	0.000585	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	5.09e-06	0.000469	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	4.99e-06	0.000459	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	3.42e-06	0.000315	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	3.36e-06	0.000309	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	3.29e-06	0.000303	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	2.26e-06	0.000208	CbGpPWpGaD
